Not currently recruiting at UCSD
Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Kite, A Gilead Company
- Links
- Gilead Clinical Trials Website
- ID
- NCT05605899
- Phase
- Phase 3 Lymphoma Research Study
- Study Type
- Interventional
- Participants
- Expecting 300 study participants
- Last Updated